Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Shares Outstanding (Weighted Average): 2019-2024

Historic Shares Outstanding (Weighted Average) for Atea Pharmaceuticals (AVIR) over the last 6 years, with Dec 2024 value amounting to $84.5 million.

  • Atea Pharmaceuticals' Shares Outstanding (Weighted Average) rose 0.22% to $83.3 million in Q4 2022 from the same period last year, while for Dec 2020 it was $82.6 million, marking a year-over-year change of. This contributed to the annual value of $84.5 million for FY2024, which is 1.23% up from last year.
  • Per Atea Pharmaceuticals' latest filing, its Shares Outstanding (Weighted Average) stood at $84.5 million for FY2024, which was up 1.23% from $83.4 million recorded in FY2023.
  • Over the past 5 years, Atea Pharmaceuticals' Shares Outstanding (Weighted Average) peaked at $84.5 million during FY2024, and registered a low of $82.6 million during FY2020.
  • Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $83.4 million (2023), whereas its average is $83.7 million.
  • Data for Atea Pharmaceuticals' Shares Outstanding (Weighted Average) shows a peak YoY climbed of 4.26% (in 2020) over the last 5 years.
  • Over the past 5 years, Atea Pharmaceuticals' Shares Outstanding (Weighted Average) (Yearly) stood at $82.6 million in 2020, then rose by 0.59% to $83.1 million in 2021, then climbed by 0.22% to $83.3 million in 2022, then increased by 0.18% to $83.4 million in 2023, then grew by 1.23% to $84.5 million in 2024.